-
1
-
-
33746821379
-
A new look at osteoporosis outcomes: The influence of treatment, compliance, persistence, and adherence
-
Badamgarav E, Fitzpatrick L. A new look at osteoporosis outcomes: the influence of treatment, compliance, persistence, and adherence. Mayo Clinic Proc. 2006;81(8):1009-1012. (Pubitemid 44175010)
-
(2006)
Mayo Clinic Proceedings
, vol.81
, Issue.8
, pp. 1009-1012
-
-
Badamgarav, E.1
Fitzpatrick, L.A.2
-
2
-
-
77949534844
-
-
International Osteoporosis Foundation, Accessed December 9 2007
-
International Osteoporosis Foundation. The adherence gap: why osteoporosis patients don't continue with treatment. http://www.iofbonehealth. org/download/osteofound/filemanager/publications/pdf/adherence-gap-report.pdf. Accessed December 9, 2007.
-
The Adherence Gap: Why Osteoporosis Patients Don't Continue with Treatment.
-
-
-
4
-
-
0004851872
-
Randomised trial of effect of alendronate on risk of fracture in women with existing vertebral fractures
-
DOI 10.1016/S0140-6736(96)07088-2
-
Black DM, Cummings SR, Karpf DB, et al; Fracture Intervention Trial Research Group. Randomized trial of effect of alendronate on risk of fracture in women with existing vertebral fractures. Lancet. 1996;348:1535-1541. (Pubitemid 26411651)
-
(1996)
Lancet
, vol.348
, Issue.9041
, pp. 1535-1541
-
-
Black, D.M.1
Cummings, S.R.2
Karpf, D.B.3
Cauley, J.A.4
Thompson, D.E.5
Nevitt, M.C.6
Bauer, D.C.7
Genant, H.K.8
Haskell, W.L.9
Marcus, R.10
Ott, S.M.11
Torner, J.C.12
Quandt, S.A.13
Reiss, T.F.14
Ensrud, K.E.15
-
5
-
-
0033552255
-
Effects of risedronate treatment on vertebral and nonvertebral fractures in women with postmenopausal osteoporosis: A randomized controlled trial
-
DOI 10.1001/jama.282.14.1344
-
Harris ST, Watts NB, Genant HK, et al. Effects of risedronate treatment on vertebral and non-vertebral fractures in women with post menopausal osteoporosis: a randomized controlled trial. Vertebral Efficacy With Risedronate Therapy (VERT) Study Group. JAMA. 1999;282:1344-1352. (Pubitemid 29483192)
-
(1999)
Journal of the American Medical Association
, vol.282
, Issue.14
, pp. 1344-1352
-
-
Harris, S.T.1
Watts, N.B.2
Genant, H.K.3
McKeever, C.D.4
Hangartner, T.5
Keller, M.6
Chesnut III, C.H.7
Brown, J.8
Eriksen, E.F.9
Hoseyni, M.S.10
Axelrod, D.W.11
Miller, P.D.12
-
6
-
-
0035857351
-
NIH consensus development panel on osteoporosis prevention, diagnosis, and therapy. Osteoporosis prevention, diagnosis, and therapy
-
NIH Consensus Development Panel on Osteoporosis Prevention, Diagnosis, and Therapy. Osteoporosis prevention, diagnosis, and therapy. JAMA. 2001;285: 785-795.
-
(2001)
JAMA
, vol.285
, pp. 785-795
-
-
-
7
-
-
0030763532
-
Effect of calcium and vitamin D supplementation on bone density in men and women 65 years of age or older
-
DOI 10.1056/NEJM199709043371003
-
Dawson-Huges B, Harris SS, Krall EA, et al. Effect of calcium and vitamin D supplementation on bone density in men and women 65 years of age or older. N Engl J Med. 1997;337:670-676. (Pubitemid 27375473)
-
(1997)
New England Journal of Medicine
, vol.337
, Issue.10
, pp. 670-676
-
-
Dawson-Hughes, B.1
Harris, S.S.2
Krall, E.A.3
Dallal, G.E.4
-
8
-
-
34247276595
-
Adherence to Medications for the Treatment of Osteoporosis
-
DOI 10.1016/j.rdc.2006.07.003, PII S0889857X06000676, Osteoporosis
-
Silverman S. Adherence to medications for the treatment of osteoporosis. Rheum Dis Clin North Am. 2006;32:721-731. (Pubitemid 46613878)
-
(2006)
Rheumatic Disease Clinics of North America
, vol.32
, Issue.4
, pp. 721-731
-
-
Silverman, S.1
-
9
-
-
33745683770
-
Adherence and persistence associated with the pharmacologic treatment of osteoporosis in a managed care setting
-
DOI 10.1097/01.smj.0000221637.90495.66, PII 0000761120060600000005
-
Downy T, Foltz S, Bocuzzi S. Adherence and persistence associated with the pharmacologic treatment of osteoporosis in a managed care setting. South Med J. 2006;99:570-575. (Pubitemid 43999919)
-
(2006)
Southern Medical Journal
, vol.99
, Issue.6
, pp. 570-575
-
-
Downey, T.W.1
Foltz, S.H.2
Boccuzzi, S.J.3
Omar, M.A.4
Kahler, K.H.5
-
10
-
-
27844518271
-
Compliance with osteoporosis medications
-
DOI 10.1001/archinte.165.20.2414
-
Solomon DH, Avorn J, Katz JN, et al. Compliance with osteoporosis medications. Arch Intern Med. 2005;165:2414-2419. (Pubitemid 41640855)
-
(2005)
Archives of Internal Medicine
, vol.165
, Issue.20
, pp. 2414-2419
-
-
Solomon, D.H.1
Avorn, J.2
Katz, J.N.3
Finkelstein, J.S.4
Arnold, M.5
Polinski, J.M.6
Brookhart, M.A.7
-
11
-
-
33745069049
-
How can osteoporosis patients benefit more from their therapy? Adherence issues with bisphosphonate therapy
-
DOI 10.1345/aph.1G534
-
Gold DT, Alexander IM, Ettinger MP. How can osteoporosis patients benefit more from their therapy? Adherence issues with bisphosphonate therapy. Ann Pharmacother. 2006;40:1143-1150. (Pubitemid 43886973)
-
(2006)
Annals of Pharmacotherapy
, vol.40
, Issue.6
, pp. 1143-1150
-
-
Gold, D.T.1
Alexander, I.M.2
Ettinger, M.P.3
-
12
-
-
0011391701
-
Basics of qualitative research: Grounded theory
-
McElroy S, ed. Newbury Park, CA: Sage
-
Strauss A, Corbin J. In: McElroy S, ed. Basics of Qualitative Research: Grounded Theory, Procedures and Techniques. Newbury Park, CA: Sage; 1990.
-
(1990)
Procedures and Techniques
-
-
Strauss, A.1
Corbin, J.2
-
14
-
-
84862755563
-
-
Accessed January 29 2008
-
Partners Healthcare System-LMR. https://lmr.partners.org/cleartrust/ct- logon.asp?CTAuthMode-BASIC&language-en&CT-ORIG-URL-https://lmr. partners.org. Accessed January 29, 2008.
-
Partners Healthcare System-LMR.
-
-
|